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The DEAH-box splicing factor Prp16 unwinds RNA duplexes
in vitro
Yan Wang*, John D.O. Wagner† and Christine Guthrie*
Background: During pre-mRNA splicing, dynamic rearrangement of RNA
secondary structure within the spliceosome is crucial for intron recognition and
formation of the catalytic core. Splicing factors belonging to the DExD/DExH-
box family of RNA-dependent ATPases are thought to have a central role in
directing these rearrangements by unwinding RNA helices. Proof of this
hypothesis has, however, been conspicuously lacking.
Results: Prp16 is a DEAH-box protein that functions in the second step of
splicing in vitro. Using various RNA duplexes as substrate, we have shown that
Prp16 has an ATP-dependent RNA unwinding activity. This activity is
independent of sequence in either the single-stranded or duplexed regions of
the RNA substrate. A mutation (prp16-1) near the ATP-binding motif of Prp16
inhibits both the RNA-dependent ATPase activity and the ATP-dependent RNA
unwinding activity.
Conclusions: Our findings provide strong biochemical evidence that Prp16 can
disrupt a duplexed RNA structure on the spliceosome. Because the purified
protein lacks sequence specificity in unwinding RNA duplexes, targeting of the
unwinding activity of Prp16 in the spliceosome is likely to be determined by
other interacting protein factors. The demonstration of unwinding activity will
also help our understanding of how the fidelity of branchpoint recognition is
controlled by Prp16.
Background
The precise removal of introns from eukaryotic pre-
mRNAs by splicing is crucial to the accurate expression of
genetic information. Splicing is carried out by a large
ribonucleoprotein (RNP) complex, the spliceosome,
which is composed of five small nuclear RNAs (snRNAs;
U1, U2, U4, U5 and U6) and around 50 protein compo-
nents [1–6]. The two-step chemical reaction in mRNA
splicing is identical to that in group II RNA self-splicing
[3]. In the first step, the 5′ splice site is attacked by the
branchpoint adenosine, resulting in cleavage at the 5′
splice site and formation of the lariat intermediate; in the
second, the 5′ OH group of exon 1 attacks the 3′ splice
site, causing cleavage at the 3′ splice site and ligation of
the two exons to form the mature mRNA (Figure 1). As
group II self-splicing introns require no assistance from
protein factors in vitro, it is generally believed that the cat-
alytic center in mRNA splicing is also formed by the RNA
components of the spliceosome. 
The RNA–RNA interactions in the spliceosome are both
complex and dynamic [2–5,7]. Genetic and biochemical
analyses have identified specific and conserved interac-
tions among snRNAs, as well as between snRNAs and
pre-mRNA, that are required for different stages of splic-
ing. Many of the interactions are mutually exclusive; that
is, formation of one helix often requires the disruption of
another [8]. For instance, the base pairs formed during
spliceosome assembly between U1 snRNA and residues at
the 5′ splice site of the pre-mRNA need to be disrupted
before the first chemical step to allow the formation of
base pairs between U6 snRNA and the 5′ splice site. Fur-
thermore, the helices formed between U4 and U6
snRNAs must be disrupted to allow base-pairing interac-
tions between U6 and U2 that are essential for catalysis
[5]. The ordered and efficient rearrangement of RNA
structures during splicing is likely to be accomplished
with the assistance of the protein factors in the spliceo-
some [8,9]. Prime candidates for this function are a class of
splicing factors containing the eponymous DExD or
DExH tetrapeptide motif, as well as other conserved
motifs characteristic of RNA-dependent ATPases with
known RNA-unwinding activity [8,10–12].
Seven DExD/DExH-box protein factors have thus far
been shown to be required for splicing in Saccharomyces cere-
visiae (Figure 1). Prp5, Prp28 and Brr2 (also known as
Snu246 or Slt22) function in spliceosome assembly [13–17].
Prp2 and Prp16 are required before the first and the second
chemical steps respectively [18,19]. Prp22 and Prp43 are
required for the dissociation from the spliceosome of the
mRNA and lariat intron products respectively [20,21].
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A eukaryotic translation initiation factor known as eIF-4a
is the prototype of the DExD/DExH-box family of pro-
teins. In the presence of ATP and a second protein factor,
eIF-4b, eIF-4a unwinds double-stranded RNA [22].
Therefore, the proteins in this family are typically
described as RNA helicases. In fact, few family members
have been shown to unwind RNA helices — nor do these
proteins appear to function with the efficiency and proces-
sivity characteristic of canonical DNA helicases. Notably,
in the 7 years since their discovery, unwinding activity has
not been reported for any of the DExD/DExH-box splic-
ing factors. Prp2, Prp5, Prp16, Prp22 and Brr2 do,
however, have RNA-dependent ATPase activity
[13,19,23–25]. Thus an important question is whether,
like eIF-4a, these splicing factors can couple the energy of
ATP hydrolysis to disrupt RNA base pairs. Alternatively,
ATP binding and hydrolysis may be coupled to the
binding to, or dissociation from, the spliceosome of the
DExD/DExH-box protein itself, or of other proteins,
without directly altering RNA secondary structures. To
help answer this question, a direct test of unwinding activ-
ity is essential for each of these factors. 
Prp16 is the focus of our study. This DEAH-box protein
was initially identified in a genetic screen for suppressors
of the splicing defect due to branchpoint mutations [26].
Prp16 is implicated in a proofreading pathway that influ-
ences the fidelity of branchpoint usage in splicing in vivo
[27,28]. RNA analyses in vivo showed that the splicing
intermediates formed with a mutant branchpoint are
degraded in an apparent ‘discard pathway’ in the presence
of the wild-type PRP16, whereas these aberrant interme-
diates can proceed through a productive pathway in the
presence of suppressor alleles of PRP16 [27]. Point muta-
tions near conserved DEAH-box motifs decrease the
RNA-dependent ATPase activity of Prp16 and allow the
usage of mutant branchpoints in splicing, thus establishing
a role for Prp16-dependent ATP hydrolysis in modulating
the fidelity of branchpoint recognition [28,29]. 
The Prp16 protein is required before the second chemi-
cal step of splicing in vitro. ATP hydrolysis by Prp16 cor-
relates with changes in the sensitivity of the 3′ splice site
to RNase H digestion and in the crosslinking efficiency
of several second-step splicing factors to the 3′ splice site
[30,31], indicative of a gross conformational rearrange-
ment of the spliceosome. A mutant allele, prp16-1, one of
the suppressors of mutant branchpoints, encodes a muta-
tion Y385→D (in the single-letter amino-acid code) near
the highly conserved ATP-binding motif GX4GK(T/S)
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Figure 1
A schematic illustration of the splicing
pathway and the DExD/DExH-box splicing
factors. The exons are depicted as boxes and
the intron by the line. The residues at the 5′
and 3′ splice sites and the branchpoint are
indicated. During spliceosome assembly, U1,
U2 and the U4–U6–U5 tri-snRNP become
associated with the pre-mRNA shown at the
top of the figure. The U1 and U4 snRNPs are
released from the spliceosome before the first
catalytic step. The nucleophile attacks
resulting in the formation of the
phosphodiester bonds are indicated by the
red arrows. The splicing products, the mature
mRNA and the excised lariat intron, are
released in two sequential steps. The domain
structures of the seven DExD/DExH-box
splicing factors are shown at the right. Only
part of the carboxy-terminal domain of Brr2 is
shown due to space limitations; all other
proteins are shown to scale. The sequence of
the signature tetrapeptide motif is shown for
each protein. This motif is one of the seven
motifs that are distributed over the
approximately 300 amino-acid domain
(highlighted in red) and are highly conserved
in the DExD/DExH-box proteins. In addition to
this domain, Prp2, Prp16, Prp22 and Prp43
also share extensive homology in the carboxy-
terminal domain (highlighted in blue). Prp22
contains a S1 RNA-binding motif in the
amino-terminal domain (highlighted in yellow).
The second and less conserved tetrapeptide
motif in Brr2 is also shown. The non-
homologous regions are highlighted in black.
The dashed lines indicate the steps for which
the function of each protein is required.
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[27], where X denotes any amino acid. This mutation
results in a dramatic reduction in the RNA-dependent
ATPase activity of the mutant protein Prp16-1 [32], and
blocks the conformational rearrangement observed with
the wild-type protein [31]. These results made Prp16 a
strong candidate for mediating an RNA structural
rearrangement in the spliceosome. Here, using purified
wild-type (Prp16) and mutant (Prp16-1) proteins, and
synthetic RNA substrates, we demonstrate that Prp16
can unwind RNA duplexes, whereas Prp16-1 cannot.
Thus Prp16 should be capable of disrupting a duplexed
RNA structure during splicing. These findings have sig-
nificant impact on our understanding of the function of
Prp16 in the structural rearrangement leading to the
second step of splicing and in controlling the fidelity of
branchpoint usage.
Results
Prp16 can unwind the U4–U6 duplex
Amino-terminal His6-tagged wild-type (Prp16) and
mutant (Prp16-1) proteins were expressed in Escherichia
coli and purified to homogeneity through several chro-
matographic steps (see Materials and methods). The
purity of each protein was assessed by both silver staining
and western blotting following SDS–PAGE (Figure 2a).
The purified wild-type protein is functional as demon-
strated by two assays. In the first, the recombinant Prp16
(rPrp16) could efficiently rescue the defect in the second
step of splicing of a yeast extract that has been depleted of
the endogenous Prp16 (Figure 2b). In the second, the
purified protein hydrolyzed ATP in the presence of
poly(A) RNA (Figure 2c). The observed rate of ATP
hydrolysis was similar to that observed using Prp16 puri-
fied from yeast cells [19]. Recombinant mutant Prp16-1
protein (rPrp16-1) purified in parallel with the wild-type
protein was defective in both splicing and ATP hydrolysis
(Figure 2c; data not shown). 
To test for the unwinding activity of Prp16 in vitro, we
needed to choose an RNA duplex as the substrate. Most
of the intermolecular RNA helices formed during splic-
ing are very short (< 10 bp). A striking exception is the
duplex formed between U4 and U6 snRNAs (Figure 3a).
In yeast, these two RNAs are held together stably
(Tm = 53°C) by two helices, stem I and stem II, which are
6 bp and 16 bp long, respectively [33]. Previously, the
U4–U6 duplex was used to demonstrate in vitro unwind-
ing activity of a factor purified from HeLa extract [34].
More recently, the same duplex was used to demonstrate
an unwinding activity of Prp22 and U5200, a human
homolog of Brr2 [25,35]. This prompted us to use this
stable duplex as an initial substrate for testing Prp16.
Note, however, that the U4–U6 duplex is unlikely to be
a substrate of Prp16 in vivo, as it is disrupted before the
first catalytic step, which can proceed in the absence of
Prp16 in vitro [19]. 
The U4–U6 duplex formed with T7-transcribed U4 and
U6 snRNAs was purified on a native gel (see Materials
and methods). The free U4 and U6 snRNAs under dena-
turing conditions (3 minutes at 95°C) did not reanneal
during the time course of the reaction (Figure 4, lane 1;
data not shown). In the absence of either Prp16 or ATP
(Figure 4, lanes 2,3), a low (about 10%) and reproducible
level of free U4 and U6 snRNA was observed. As this
background level of free U4 and U6 remained constant
during an incubation period as long as 1 hour when either
ATP or Prp16 (or both) were omitted (data not shown), it
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Figure 2
Characterization of purified recombinant Prp16 (rPrp16) and Prp16-1
(rPrp16-1). (a) Visualization of the purified proteins by western blot
analysis using polyclonal anti-Prp16 antibodies (lanes 1,2) or by silver
staining (lanes 3–5) following SDS–PAGE. Lanes 1,3, rPrp16; lanes
2,4, rPrp16-1; lane 5, the 10 kDa molecular weight ladder. (b) Rescue
by rPrp16 of in vitro splicing in a yeast extract immunodepleted of
endogenous Prp16. In vitro splicing reactions were conducted using
radiolabeled actin precursor mRNA [47]. Lane 1, wild-type yeast
splicing extract; lanes 2,3, extract immunodepleted of Prp16. To the
reaction shown in lane 3, 0.5 nM rPrp16 was added . The identities of
each band are illustrated to the right of the gel, and they denote (from
top to bottom) the lariat intermediate, lariat intron, precursor mRNA,
mature mRNA and 5′ exon. (c) The ATPase activity of the purified wild-
type and mutant rPrp12 proteins. The rate of hydrolysis plotted reflects
the initial rate determined from a time course of 12 min using
equation 3 (see Materials and methods).
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is probably generated during the preparation of the sub-
strate. When both Prp16 and ATP were present (Figure 4,
lanes 4,6), a significant fraction of the duplex was con-
verted to single-stranded RNAs, indicating unwinding
activity. Very importantly, when the wild-type protein was
replaced with Prp16-1 protein, no unwinding was
observed (Figure 4, lanes 7,8). This demonstrates that the
observed unwinding activity is intrinsic to Prp16, and is
not due to a contaminating activity that co-purifies with
the protein. Thus we conclude that Prp16 exhibits ATP-
dependent U4–U6 unwinding activity in vitro. 
We noted that the efficiency of unwinding was sensitive
to the reaction conditions, because the activity was higher
when HEPES-KOH (pH 7.9) and KOAc were used in
place of Tris-HCl (pH 8.0) and KCl (Figure 4, compare
lanes 4 and 6). This difference is predominantly due to
the effect of acetate versus chloride anions (data not
shown). It has been reported that binding of proteins to
nucleic acids is more stable in acetate than it is in chloride;
moreover, RNA binding can be shown to be coupled to
ATP binding in acetate but not in chloride [36–38]. The
E. coli Rho protein is also known to unwind RNA–DNA
duplexes with higher efficiency and processivity in acetate
than in chloride [39]. It remains to be investigated
whether, in the case of Prp16, the effect of acetate versus
chloride is on RNA binding, RNA unwinding or the cou-
pling between the binding of RNA and the binding of
ATP.
Hydrolyzable nucleoside triphosphate is required for
unwinding
Prp16 has a broad specificity for nucleoside triphosphates in
both hydrolysis and splicing. In fact, all four ribonucleoside
triphosphates (NTPs) and the four deoxynucleoside
triphosphates (dNTPs) can be hydrolyzed by Prp16 and uti-
lized by it to complement the second step of splicing [30]. If
the RNA-unwinding activity we observed for Prp16 is rele-
vant to its function in splicing, the same broad specificity for
444 Current Biology, Vol 8 No 8
Figure 3
Sequences and structures of the RNA substrates used in the
unwinding assay. (a) The sequence of U4 and U6 snRNA and the
predicted structure of the U4–U6 duplex [33]. The base pairs in stem I
and stem II are highlighted in purple and red, respectively. The dot in
stem I indicates a G–U base pair, and the break in stem II indicates the
bulge. Residues that form intramolecular base pairs are underlined.
The inset shows the alternative structure of stem II. (b) The sequence
and predicted structure of the DY duplex (see later). (c) The sequence
and predicted structure of the truncated DY substrates DY∆5′ and
DY∆3′ (see later). In both (b) and (c), the base pairs in the duplexed
region are highlighted in red, and the numbers indicate the length in
base pairs of the single-stranded and double-stranded regions. 
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Stem I Stem II
Figure 4
Prp16 unwinds the U4–U6 duplex in the presence of ATP. Unwinding
reactions were carried out at 30°C for 20 min before the addition of an
equal volume of the stop solution (see Materials and methods). Lane 1,
the sample was boiled before loading onto the gel; lane 2, no rPrp16;
lanes 3–6, 20 nM rPrp16; lanes 7,8, 20 nM rPrp16-1. ATP was
included in the reactions shown in the even-numbered lanes. Tris-HCl
pH 8.0 and KCl were used in the reactions shown in lanes 3 and 4;
HEPES-KOH pH 7.9 and KOAc were used in all other reactions. The
U4–U6 duplex and the individual monomers are identified to the left of
the gel. The percentage of single-stranded RNA (ssRNA) was
determined using equation 1 (see Materials and methods).
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nucleoside triphosphates is expected. This was indeed the
case. As shown in Figure 5a, both NTPs and dNTPs could
be utilized by Prp16 in unwinding the U4–U6 duplex. The
unwinding activity observed with the non-ATP nucleoside
triphosphates could not be due to contamination with ATP,
because the values of both the Michaelis constant (Km) and
the turnover number (kcat) for each of the nucleoside
triphosphates were very similar (Table 1). 
ATP hydrolysis by Prp16 is absolutely essential for its
function in splicing. To test whether the RNA-unwinding
activity of Prp16 has the same requirement, we measured
the unwinding of U4–U6 by Prp16 in the presence of a
non-hydrolyzable analog of ATP, ATPγS. No unwinding
of the U4–U6 duplex was observed in the presence of
3 mM ATPγS (Figure 5b, compare lanes 2 and 11), while
significant unwinding was observed with each of the
hydrolyzable NTP and dNTPs under the same conditions.
As ATPγS is a competitive inhibitor of ATP for binding to
Prp16, and is hydrolyzed less than 0.05% as efficiently as
ATP [30], we conclude that ATP hydrolysis by Prp16 is
necessary for the unwinding of the U4–U6 duplex. 
Therefore, the three biochemical activities of Prp16 —com-
plementation of the second step of splicing, NTP hydroly-
sis, and, as revealed here, RNA unwinding — share the
same broad specificity for nucleoside triphosphate and the
same requirement for hydrolyzable nucleoside triphosphate.
Critically, a mutation in Prp16 (prp16-1) that inhibits its
function in the second step of splicing and impairs its
ATPase activity also abrogates the in vitro unwinding
activity. Furthermore, like the unwinding reaction, the
Prp16-dependent conformational rearrangement of the
spliceosome is not supported by ATPγS [30]. These
results strongly suggest that the unwinding activity we
observed is relevant to the function of Prp16 in splicing. 
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Figure 5
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Unwinding of U4–U6 by Prp16 requires ATP hydrolysis and is
supported by both NTPs and dNTPs. (a) Unwinding reactions were
conducted for 40 min at 30°C using 10 nM rPrp16 and 0.5 nM U4–U6
duplex. Dilutions of each of the nucleoside triphosphates were made in
equal molar concentration of MgCl2. The reaction buffer contained an
additional 0.5 mM MgCl2, so that the concentration of Mg2+ is 0.5 mM
higher than that of the nucleoside triphosphate for all reactions. Solid
lines, fitted curves for ribonucleoside triphosphates; dashed lines,
fitted curves for deoxynucleoside triphosphates. (b) Unwinding
reactions were conducted for 20 min using 20 nM rPrp16 and 0.5 nM
U4–U6 duplex. Lane 1, the sample was boiled before loading onto the
gel; lane 2, no added nucleoside triphosphate. Reactions shown in
lanes 3–11 contain 3 mM of the indicated NTPs.
Table 1
Comparison of the Km and kcat values of various nucleoside
triphosphates in supporting the unwinding activity of Prp16.
NTPs/dNTPs Km (mM) kcat × 104 (min–1)
ATP 0.26 ± 0.07 6.9 ± 0.6
CTP 0.34 ± 0.04 6.5 ± 0.3
GTP 0.34 ± 0.08 7.3 ± 0.6
UTP 0.58 ± 0.10 7.0 ± 0.5
dATP 0.30 ± 0.05 7.7 ± 0.4
dCTP 0.41 ± 0.09 6.7 ± 0.5
dGTP 0.27 ± 0.02 7.7 ± 0.2
dTTP 0.49 ± 0.09 7.3 ± 0.5
The values of Km and kcat were determined by curve fitting of the data
shown in Figure 5a to the Michaelis–Menten equation. The standard
deviation was determined from curve fitting.
The unwinding activity of Prp16 is sequence-nonspecific
As mentioned earlier, the U4–U6 duplex is unlikely to be
the spliceosomal target of the unwinding activity of
Prp16. The fact that this duplex substrate is efficiently
disrupted suggests that Prp16 may not require a specific
RNA sequence in the in vitro unwinding assay. We tested
this possibility in two ways. First, a duplex substrate was
made from antisense U4 and U6 snRNAs (asU4–asU6).
The sequence and the backbone polarity of both the
single-stranded and the double-stranded regions of this
substrate are distinct from those of the U4–U6 substrate.
The structure and stability of the duplexed regions were,
however, expected to be the same. If a specific sequence
element in either the single-stranded or the double-
stranded region of the U4–U6 duplex is required for the
unwinding activity of Prp16, the antisense duplex should
not be disrupted. In order to facilitate quantitative com-
parison of the unwinding efficiencies, the synthesis,
purification, and concentration determination of U4–U6
and asU4–asU6 substrates were conducted in parallel. In
addition, a complete time course was taken which
allowed us to obtain the initial rates of the two reactions.
As shown in Figure 6, both the sense (Figure 6a) and the
antisense (Figure 6b) substrates were unwound by Prp16.
The initial rate was obtained by fitting the data to a first-
order kinetic equation (see Materials and methods)
(Figure 6d, Table 2). The efficiency with which Prp16
unwound each of the two substrates was essentially indis-
tinguishable. Thus, we conclude that no specific
sequence element appears to be required for the unwind-
ing of U4–U6 duplex by Prp16. It is conceivable,
however, that a unique RNA structure in either the
single-stranded or the double-stranded regions of
U4–U6, which is maintained in the antisense substrate,
may be required by Prp16 to allow unwinding.
We therefore took a second approach to test the substrate
specificity of the unwinding activity of Prp16, using a sub-
strate that is unrelated to U4–U6 in either sequence or
446 Current Biology, Vol 8 No 8
Figure 6
Comparison of the efficiency of unwinding of
several RNA duplexes by Prp16. 
(a–c) Autoradiographs of time courses
comparing unwinding of (a) U4–U6, 
(b) asU4–asU6 and (c) DY duplexes (see
later). (d) Quantitation and curve fitting using
equations 1 and 2, respectively (see Materials
and methods). The percentage of ssRNA
determined for each time point from the data
presented in a–c is shown for U4–U6
(circles), asU4–asU6 (triangles) and DY
duplex (squares). The lines are generated
using equation 2 with the kobs presented in
Table 2. The concentrations of Prp16 and
each of the RNA substrates used were 5 nM
and 0.5 nM, respectively. The apparent
mobility shift of the bands over time is the
result of continuous electrophoresis during
the loading of samples between successive
time points. 
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Table 2
The observed initial rate constants (kobs) for the unwinding of
RNA duplex by Prp16.
RNA substrate kobs × 100 (min–1)
5 nM Prp16 10 nM Prp16 20 nM Prp16
U4–U6 2.0 ± 0.1 10 ± 1 11 ± 1
asU4–asU6 1.9 ± 0.1 6.0 ± 0.6 8 ± 1
DY 1.2 ± 0.3 2.6 ± 0.2 n.d.
DY∆5′ 0.7 ± 0.1 1.5 ± 0.1 n.d.
DY∆3′ 0.2 ± 0.1 0.4 ± 0.1 n.d.
The standard deviation was determined from curve fitting. For the
asU4/asU6 substrate, the amplitude (A1) in equation 2 was fixed as
80% in curve fitting to achieve the best fit of the experimental data:
n.d., not determined.
structure. A double-Y substrate (DY; Figure 3b), contain-
ing four single-stranded tails (of about 30 nucleotides
each) and an 18 bp duplex, was synthesized for this
purpose (see Materials and methods). On the basis of its
sequence, no additional secondary structure was expected
to form in this substrate. The length and the stability of
the duplex were chosen to resemble that of U4–U6 stem
II, so that the unwinding efficiency of the two substrates
could be directly compared. As shown in Figure 6c, the
DY duplex was efficiently converted to single-stranded
RNA by Prp16. Quantitative analyses revealed a differ-
ence of only 2–3-fold in the rate of unwinding of the DY
duplex compared with that of the U4–U6 duplex
(Figure 6d, Table 2). Taken together, the results from
these two approaches show that Prp16 exhibits a general
ability to unwind RNA helices and does not require spe-
cific sequences in the substrate RNA.
This conclusion does not rule out the possibility that RNA
sequence and structure could influence the efficiency of
unwinding. For instance, the U4–U6 duplex does contain
an intrinsic structural feature which could facilitate the
unwinding reaction mediated by Prp16, and by other pro-
teins with unwinding activity. As shown in the inset in
Figure 3a, the residues in U4 and U6 that form stem II can
also form intramolecular stem-loop structures. These
alternative structures could facilitate the unwinding of
U4–U6 duplex by preventing the reverse reaction, the
reannealing of the U4–U6 stem II. 
It has been reported previously that the ATPase activity
of Prp16 is more efficiently stimulated by poly(A) and
poly(U) than by poly(G) and poly(C) [30]. Therefore, an
AU-rich RNA substrate might be unwound more effi-
ciently than a GC-rich one, not only because it is less able
to form intramolecular secondary structures, but also
because it should more efficiently stimulate the ATPase
activity of Prp16. In addition to ATPase activation, the
binding interactions between Prp16 and different RNA
substrates may also be influenced by sequence composi-
tion as well as by RNA structure, which in turn could
influence the unwinding activity in vitro; this could be
particularly significant because the unwinding activity of
Prp16 has been measured in the presence of subsaturating
amounts of RNA and protein. Comparisons of RNA
binding, ATPase activation and unwinding in parallel,
using a number of RNA substrates, will be necessary to
further understand the mechanism of unwinding.
A 3′-tailed substrate is preferred
The DNA-unwinding or RNA-unwinding activity of many
previously characterized proteins has been classified as 5′-
to-3′, 3′-to-5′ or bidirectional, on the basis of the require-
ment for a 5′ tail, a 3′ tail, or either, respectively [40]. To
determine whether the unwinding activity of Prp16 also
requires one or both single-stranded tails, either the two 5′
tails or the two 3′ tails of the DY duplex were deleted
(Figure 3c). The Prp16-dependent unwinding of the two
substrates were compared in parallel. As shown in
Figure 7 and Table 2, the 3′-tailed substrate (DY∆5′) was
unwound more efficiently than the 5′-tailed substrate
(DY∆3′). As the duplexed regions of the two substrates are
identical, the difference in the unwinding efficiency
reflects a preference of Prp16 for unwinding the 3′-tailed
over the 5′-tailed RNA duplex in this particular substrate.
However, it should be stressed that the sequences in the
5′ and the 3′ single-stranded regions, though designed to
be similar, are not identical. Thus, as discussed in the pre-
vious section, our results do not rule out the possibility
that the difference in sequence could cause or exacerbate
the preference for the 3′-tailed substrate.
Discussion
The demonstration that Prp16 exhibits NTP-hydrolysis-
dependent unwinding activity has significant impact on
understanding how Prp16 may function in the second
step of splicing and, in particular, in controlling the
fidelity of branchpoint usage. As reviewed above, a gross
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Figure 7
Prp16 unwinds a 3′-tailed duplex more efficiently. (a) Autoradiograph
of the unwinding of DY∆3′ (left) and DY∆5′ (right) by Prp16. The
reaction conditions were as described in Figure 6. (b) Quantitation
and curve fitting using equations 1 and 2 were as described in
Figure 6. Circles, DY∆3′; squares, DY∆5′.
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conformational rearrangement before the second cat-
alytic step is dependent on the hydrolysis of ATP by
Prp16, and is blocked in the presence of mutant Prp16-1
protein, a suppressor of branchpoint mutations [30,31]. It
has been proposed that the fidelity of branchpoint usage
is controlled by the rate of ATP hydrolysis by Prp16 rela-
tive to the rate of the conformational rearrangement
[28,29]. We have shown here that the RNA-unwinding
activity of Prp16-1 is also defective. Thus, the rate of
unwinding of a particular RNA structure by Prp16 may
control the fidelity of branchpoint usage. A suppressor
allele containing a point mutation directly upstream of
the conserved SAT motif (T504→I, in the single-letter
amino-acid code) has only a modest (about 20% of wild
type) reduction in ATPase activity, but is as efficient a
suppressor as is the prp16-1 allele. Mutations in this
motif in eIF-4a have a greater detrimental effect on
unwinding than on ATP hydrolysis [41]. Further analy-
ses of the unwinding activity from this and other sup-
pressor alleles should provide insight into the precise
mechanism by which Prp16 controls the fidelity of
branchpoint usage.
In contrast to the classical DNA helicases, which unwind
DNA duplexes efficiently and processively [40], the
unwinding of RNA duplexes by DExD/DExH-box pro-
teins often requires an excess of protein over the nucleic
acid substrate and proceeds at a slower rate. In the case
of Prp16, a 10–40-fold excess of protein to RNA sub-
strate is needed for efficient unwinding. This require-
ment could be explained in several ways. In the first
case, multiple protein molecules may need to associate
with each RNA duplex to allow efficient unwinding. As
the association state of Prp16 in solution or when bound
to RNA is still unknown, it remains to be determined
whether the formation of multimeric Prp16 may con-
tribute to the requirement for excess protein in unwind-
ing. Alternatively, if the concentration of the RNA
substrate is significantly below the dissociation constant
(Kd) of the protein–RNA complex, excess protein would
be required to drive the formation of the protein–RNA
complex. Two lines of evidence support this explanation.
First, the unwinding reaction is subsaturating, as
reflected by the increase in the rate constant with an
increase in Prp16 concentration from 5 nM to 10 nM
(Table 2). Second, the Kd for Prp16–U6 complex is
approximately 50 nM (Y.W. and C.G., unpublished
observations). At 0.5 nM, the concentration of the RNA
duplex is significantly below the Kd; thus excess amounts
of Prp16 would be required to allow efficient binding to
the substrate. Finally, the presence of an inactive frac-
tion of Prp16 could also contribute to the observed
requirement for excess protein. Thus the important
mechanistic question of whether Prp16 can function stoi-
chiometrically or substoichiometrically in unwinding
RNA requires further investigation.
Recently, two other DExD/DExH-box splicing factors,
Prp22 and U5200, the human homolog of Brr2, have been
shown to unwind RNA duplexes in vitro, also in a
sequence-nonspecific fashion [25,35]. The challenge now
is to identify the spliceosomal target of the unwinding
activity of each factor. As Prp16, Prp22 and Brr2 are each
required for distinct steps in splicing (see Figure 1), it is
likely that the target of the unwinding activity also differs
for each factor. As a component of the U5 snRNP, which
functions before the first catalytic step, U5200 has been
proposed to unwind the U4–U6 duplex on the spliceo-
some [35]. Indeed, it was recently demonstrated that a
mutation near a conserved ATPase motif in Brr2 (brr2-1;
[17]) blocks the disruption of the U4–U6 duplex con-
tained in a multi-snRNP complex, consistent with a role
for this protein in unwinding U4–U6 on the spliceosome
(P. Ragunathan and C.G., unpublished observations).
Because the unwinding activity of these three purified
DExD/DExH-box proteins is sequence-nonspecific in
vitro, it is likely that recognition of the spliceosomal RNA
substrate is achieved through other interacting protein
factors. The complementation of the second step of splic-
ing requires much less Prp16 protein (0.5 nM) than does
the unwinding reaction. This is consistent with the possi-
bility that the association of Prp16 with the spliceosome is
facilitated by interactions with other splicing factors. 
Recently, we showed that the non-conserved amino-ter-
minal domain is required for the specific binding of Prp16
to the spliceosome (Y.W. and C.G., unpublished observa-
tions). An attractive hypothesis is that the unwinding
activity intrinsic to the conserved DEAH-box domain of
Prp16 is directed to its target through the interaction
between the amino-terminal domain and its spliceosomal
binding site. In principle, once in contact with a single-
stranded region of snRNA or pre-mRNA, Prp16 could
unwind an adjacent duplexed structure in an NTP-depen-
dent and sequence-independent manner. This hypothesis
is reminiscent of the mechanism by which U2AF65 accom-
plishes position-specific, sequence non-specific annealing
of U2 snRNA to the branchpoint by tethering the anneal-
ing domain to a sequence-specific RNA recognition motif
in a separate domain of the same protein [42].
The strategy of using non-conserved domain(s) to deter-
mine the specificity of the highly conserved
DExD/DExH domain is likely to be shared by many
members of this protein family. Motifs that have been
widely implicated in protein–RNA interactions and
protein–protein interactions have also been identified in
the non-conserved domains of other DExD/DExH-box
proteins [20,43–45]. The interactions of the
DExD/DExH-box splicing factors with their RNA sub-
strates are likely to be transient during splicing; therefore,
identification of the spliceosomal components with which
these factors interact could provide important clues to the
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identity of the biological targets. As most of the
DExD/DExH-box proteins have been identified through
sequence homology, the link between their biochemical
activity (ATP hydrolysis and/or RNA unwinding) and
their biological function has yet to be established. In this
respect, the study of the spliceosomal DExD/DExH-box
proteins serves as a stepping stone to revealing the biolog-
ical importance of this rapidly growing protein family. 
Conclusions
The DExD/DExH-box ATPases are involved in diverse
cellular functions that involve large RNP complexes. They
are generally believed to mediate structural rearrange-
ments in nucleic acids that result in disruption of base-
pairing interactions. Until recently, none of the seven
DExD/DExH-box splicing factors found in S. cerevisiae had
been demonstrated to unwind RNA. Here, using synthetic
RNAs as substrates, we have demonstrated that Prp16, a
DEAH-box protein required for the second step of splic-
ing, can indeed unwind RNA duplex in vitro. This activity
of Prp16 exhibits a broad specificity for nucleoside triphos-
phate, and is not supported by a non-hydrolyzable analog
of ATP, ATPγS. Notably, the unwinding activity of Prp16
is sequence-nonspecific. Our findings provide biochemical
evidence that Prp16 should be capable of directly mediat-
ing RNA structural rearrangement during splicing by
unwinding an RNA duplex. 
Materials and methods
General reagents
Restriction enzymes were purchased from New England Biolabs.
Radiolabeled nucleotides were purchased from Amersham. T7 RNA
polymerase, poly(A), and ultrapure solutions of NTP/dNTPs were from
Pharmacia. Ni–NTA resin was from Qiagen. Poly(U)–agarose resin and
ATPγS were from Sigma. Polyacrylamide gel electrophoresis and chro-
matography materials were purchased from Bio-Rad. Oligonucleotides
were synthesized by Operon. 
Expression and purification of Prp16 from E. coli
Cell lysis: Prp16 was overexpressed in E. coli (Y.W. and C.G., unpub-
lished observations). Typically, cells from 1 liter cultures were har-
vested, washed in 100 ml TE, then resuspended in equal volumes of
the lysis buffer, buffer A (20 mM HEPES-KOH pH 7.9, 150 mM KCl,
10% glycerol, 0.1% NP40, 1 mM PMSF). Then, 0.4 mg/ml lysozyme
was added, followed by incubation on ice for 45 min with gentle mixing
every 15 min. The mixture was then frozen in liquid N2 and thawed in a
water bath at room temperature to further lyse the cells. DNase I (50 µl;
2 U/µl, from USB) and MgCl2 to 10 mM were added to the lysate,
which was then incubated with rocking at 4°C until the viscosity was
reduced significantly (30–60 min). The lysate was passed through an
18 gauge needle twice to further reduce the viscosity, then centrifuged
at 30,000 rpm in a 60 Ti rotor for 1 h. The resulting supernatant was
collected for use in protein purification. 
Protein purification: Solid ammonium sulfate (Fisher) was gradually
added to the lysate to 70% saturation at 4°C (0.44 g/ml), and the
mixture was incubated with rocking at 4°C for 20 min. The precipitate
was collected by centrifugation at 15,000 rpm in a SS34 rotor
(Beckman) for 15 min, and extracted three times with 40% ammonium
sulfate (0.23 g/ml) prepared in 20 mM HEPES-KOH pH 7.9, 0.5 mM
DTT, 0.2 mM EDTA. The resulting pellet was resuspended in the
Ni–NTA binding buffer (buffer A supplemented with 5 mM imidazole
pH 7.9 and incubated with 1 ml Ni–NTA resin (pre-equilibrated with the
binding buffer) at 4°C with rocking for 1 h. The slurry was loaded onto
a column and washed with 15 ml buffer A plus 10 mM imidazole. The
bound proteins were eluted with 150 mM imidazole in buffer B (20 mM
HEPES-KOH pH 7.9, 50 mM KCl, 0.2 mM EDTA, 10% glycerol and
0.5 mM DTT). The eluate was loaded onto a phosphocellulose column
(2 ml), and washed with 20 ml buffer B-250 (the number appended to
B indicates the concentration of KCl in mM). The bound protein was
eluted sequentially with buffer B-500 and B-600. The eluates were
combined and dialyzed twice against 1.5 liters buffer B-50, then loaded
onto a poly(U)–agarose column (2 ml). The column was washed with
20 ml buffer B-100, and eluted with 3 ml each of buffer B-150 and B-
200. The peak fractions were combined and diluted to 50 mM KCl with
buffer B-0 and loaded onto a CM–Sepharose column (2 ml) pre-equili-
brated in buffer B-50. The column was washed with 20 ml  buffer B-
100 and the protein was eluted with buffer B-150. The peak fractions
were dialyzed twice against 1.5 liters of buffer C (20 mM HEPES-KOH
pH 7.9, 50 mM KCl, 0.2 mM EDTA, 20% glycerol, 0.5 mM DTT, 0.01%
NP40). The mutant protein Prp16-1 was purified using identical proce-
dures. The final concentration of the purified protein was determined by
the BioRad Bradford assay using BSA as the standard. 
Preparation of RNA substrates by in vitro transcription 
U4–U6 duplex: Plasmids (pT7U4 and pT7U6) carrying the U4 and U6
snRNA genes under the control of the T7 promoter were obtained from
John Abelson’s laboratory [46]. To increase the in vitro transcription
efficiency, the pT7U6 plasmid was modified to generate the
pT7U6(∆U) plasmid which deletes the first two U residues in the U6
snRNA. The pT7U4 and pT7U6(∆U) plasmids were linearized with the
restriction enzymes StyI and DraI, respectively. The [α-32P]UTP-
labeled U4 and U6 snRNAs (approximately 400 cpm/fmol) were syn-
thesized as run-off transcripts from the above templates using T7 RNA
polymerase. The gel-purified U4 and U6 snRNAs were combined in
40 mM Tris-HCl pH 7.4 and 100 mM KOAc, incubated at 95°C for
3 min, and slowly cooled to 37°C to allow efficient annealing. The
duplexed U4–U6 was separated from the single-stranded molecules on
a native gel (8% acrylamide (37.5:1), 0.5 × TBE). The concentration of
the duplex was determined on the basis of incorporation of the radioac-
tive nucleotide. The sequence and the predicted structure of the
U4–U6 duplex are shown in Figure 3a.
Antisense U4–U6 (asU4–asU6) duplex: The DNA templates for the
synthesis of antisense U4 and antisense U6 snRNA were generated by
PCR. Primers ASU4-1 (5′-GGAATTCTAATACGACTCACTATAG-
GAAAGGTATTCCAAAAATTCCCT-3′) and ASU4-2 (5′-CGGGATC-
CATCCTTATGCACGGG-3′) were used to amplify a PCR fragment
from pT7U4 with the T7 promoter (in ASU4-1) directly upstream of the
antisense strand of the DNA encoding U4 snRNA. Similarly, the
primers ASU6-1 (5′-GGAATTCTAATACGACTCACTATAGGAAAAC-
GAAATAAATCTCTTTGT-3′) and ASU6-2 (5′-CGGGATCCGTTCGC-
GAAGTAACCCTTCG-3′) were used to amplify the analogous
fragment from pT7U6(∆U). The resulting PCR fragments were purified
by phenol extraction and ethanol precipitation, and then used directly in
in vitro transcription to synthesize asU4 and asU6.
The double-Y (DY) duplex: The two RNA strands in the DY duplex was
synthesized from PCR templates constructed as follows. Equal amounts
of DNA oligonucleotides DY1-1 (5′-AAAACGAAATAAATCTCTTTG-
TAAAAACTCTAGAGGATCCCTTT-3′) and DY1-2 (5′-CGGGATCC-
GATTATTTAGTTTACAAAGTAGTTTAAA GGGATCCTCTAGAGT-3′),
which are partially complementary (shown in italics) were annealed and
then fully extended to generate a duplex using Pfu DNA polymerase
(Stratagene) and standard PCR conditions. The resulting fragment was
then amplified with primers DY1-2 (see above) and DY1-3 (5′-
GGAATTCTAATACGACTCACTATAGGAAAACGAAATAAATCTCTTT-
GTA-3′). DY1-3 contains the T7 promoter upstream of a region
complementary to the 5′ end of DY1-1. The resulting PCR fragment
was purified by phenol extraction and ethanol precipitation, and then
used in T7 transcription to synthesize DY1. Similarly, the template used
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to synthesize DY2 was constructed using primers DY2-1 (5′-AAAGG-
TATTCCAAAAATTCCCTTATAAAAAGGGATCCTCTAGAGTACT-3′),
DY2-2 (5′-CGGGATCCTTTTGCTTTATTTAGAGAAACATTTAGTACT-
CTAGAGGATCCC-3′) and DY2-3 (5′-GGAATTCTAATACGACTCAC-
TATAGGAAAGGTATTCCAAAAATTCCCT-3′). The sequences and
the predicted structure of the DY duplex are shown in Figure 3b.
The templates for synthesizing the two strands in DY∆5′ were generated
by substituting primer DY1-3 with DY1∆5′ (5′-GGAATTCTAATAC-
GACTCACTATAGGACTCTAGAGGATCCCTTTA-3′) and DY2-3 with
DY2∆5′ (5′-GGAATTCTAATACGACTCACTATAGGAAAGGGATC-
CTCTAGAGTA-3′) in the PCR reactions described above. To generate
the two strands in DY∆3′, the full-length PCR templates for the two
RNA strands were first digested with the restriction enzymes DraI (for
DY1) and ScaI (for DY2), respectively, and then used as templates in T7
transcription. The sequences and the predicted structures of DY∆5′ and
DY∆3′ are shown in Figure 3c.
Unwinding assay
Unless indicated otherwise, the unwinding reaction contained 40 mM
HEPES-KOH (pH 7.9), 50 mM KOAc, 1 mM DTT, 0.05 mg/ml BSA,
3 mM MgCl2, 3 mM ATP and 0.5 nM RNA substrate. Reactions con-
taining all components except ATP were preincubated at 30°C for
4 min. The reaction was initiated by the addition of ATP. A 3 µl sample
was taken from the reaction (30 µl) at the indicated time, mixed with an
equal volume of stop solution (8% glycerol, 0.4% SDS, 20 mM EDTA,
and 0.1 mg/ml protease K), and incubated for 10 min at 37°C before
loading onto a 16 × 16 × 0.075 cm non-denaturing gel (8% acrylamide
(37.5:1), 0.5 × TBE). The electrophoresis was carried out at room tem-
perature in 0.5 × TBE at a constant current of 5 mA during the time
course. The current was increased to 10 mA after the sample of the
last time point was loaded. The percentage of the single-stranded RNA
(Pss) was determined using the following equation: 
Pss = 100 × (CssRNA1 + CssRNA2)/(CssRNA1 + CssRNA2 + CdsRNA)     (1)
where C is the radioactivity of the indicated species quantified using a
PhosphorImager (Molecular Dynamics).
The initial rate constant (kobs) of the unwinding reaction was obtained
by curve fitting using the following equation:
Pss = A1– (A1–A0)exp(–kobst) (2)
where Pss represents the percentage of ssRNA at time t, A1 is the
amplitude, A0 is the percentage of ssRNA at time zero, and kobs is the
initial rate constant.
ATPase assay
The ATPase assays were carried out in the presence of 40 mM HEPES-
KOH (pH 7.9), 100 mM KOAc, 0.5 mM MgCl2, 1.0 mM ATP, 2 µg
poly(A) RNA, 5 nM protein and trace amounts of [γ-32P]ATP. Reactions
(20 µl) were initiated by the addition of the protein and were incubated at
30°C. A 1 µl sample was taken at various time points and spotted
directly onto a PEI–cellulose thin layer chromatography plate (EM
Science), which was then developed in 0.35 mM KH2PO4 buffer
(pH 7.5) to separate the inorganic phosphate from ATP. The results were
quantified using a PhosphorImager and the rate constant (k) of ATP
hydrolysis was determined by curve fitting using the following equation: 
FPi(t) = FPi(0) + kt(P/A) (3)
where FPi(t) and FPi(0) are the fraction of inorganic phosphate at time t
and time zero, respectively, A and P are the initial concentrations of
ATP and protein, respectively, and k is the initial rate constant.
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